• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Organisation › Details

Sequenom (Group)

Sequenom, Inc. (Nasdaq: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. *

 

	Start	1994-01-01 established
	Industry	genomics/genetics
	Region	San Diego, CA
	Country	United States (USA)
	Street	3595 John Hopkins Court
	City	92121-1331 San Diego, CA
	Tel	+1-858-202-9000
	Fax	+1-858-202-9001
		Address record changed: 2008-12-07
Basic data	Employees	n. a.
	Currency	USD
	Annual sales	37,863,000 (revenues, total, consolidated (2009) 2009-12-31)
	Profit	-71,012,000 (2009-12-31)
	Cash	42,681,000 (2009-12-31)
		* Document for »About Section«: Sequenom, Inc.. (12/22/10). "Press Release: Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test". San Diego, CA.
		Record changed: 2011-11-25

More documents for Sequenom (Group)

• [1] Atlas Biolabs GmbH. (7/23/10). "Press Release: Atlas Biolabs Expands Services in Molecular Genetics to High-throughput SNP-genotyping Based on Mass Spectrometry". Berlin....
• [2] Sequenom, Inc.. (5/12/10). "Press Release: Sequenom Announces $51.6 Million Private Placement". San Diego, CA....
• [3] Sequenom, Inc.. (4/19/10). "Press Release: Sequenom Introduces the MassARRAY Analyzer 4 System. Next-generation Proprietary Platform Makes High-performance Mass Spectrometry Available to Broad Market". San Diego, CA....
• [4] Sequenom, Inc.. (3/15/10). "Press Release: Sequenom Reports 2009 Fourth Quarter and Full Year Financial Results. Full Year 2009 Revenues of $37.9 Million with Year End Cash and Equivalents of $42.7 Million". San Diego, CA....
• [5] Sequenom, Inc.. (2/16/10). "Press Release: Sequenom Announces Launch of SensiGene Fetal(XY) (Fetal Sex Determination)". San Diego, CA....
• [6] Sequenom, Inc.. (2/9/10). "Press Release: Sequenom Licenses Worldwide Rights to Develop Age-related Molecular Degeneration Diagnostic Test". San Diego, CA....
• [7] Sequenom, Inc.. (2/4/10). "Press Release: Sequenom Announces Launch of SensiGene Fetal RHD genotyping Test. First Commercial Test Using SEQureDx Technology for Determining Rhesus D Incompatibility". San Diego, CA....
• [8] Sequenom, Inc.. (9/28/09). "Press Release: Sequenom Announces Completion of Independent Investigation". San Diego, CA....
• [9] Sequenom, Inc.. (9/17/09). "Press Release: Sequenom Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test. First Commercial Test from Sequenom Center for Molecular Medicine". San Diego, CA....
• [10] Sequenom, Inc.. (9/9/09). "Press Release: Sequenom Announces Partnership with Geneworks for Sales and Marketing of MassARRAY Systems and Applications in Australia". San Diego, CA....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.